Abstract
New possibilities for the diagnosis and treatment of reproductive and genetic disorders are becoming available as a result of a series of recent technical advances. Intracytoplasmic sperm injection (ICSI) allows treatment of numerous infertile men whose sperm cannot penetrate the egg to initiate fertilization. Molecular genetic testing provides clients of reproductive age with additional information that permits prevention of genetic diseases such as fragile X syndrome, the leading cause of inherited mental retardation. Preimplantation genetic testing (PGT) offers couples who carry genetic disorders the prospect of having children with a greatly decreased risk of initiating a pregnancy involving an affected individual. Flow-cytometric sperm separation offers a new, effective approach for prevention of X-linked genetic disorders. Two major causes of recurrent pregnancy loss (RPL) involve recurrent trisomies and immunological disorders. Of the latter, 70% of studied populations of patients can attain live births with simple treatment protocols. Maternal serum assays involving multiple markers reduce both false positives and false negatives in detection of trisomies. Despite these advances in research, many safe and effective methods of diagnosis and treatment remain under-utilized in the clinical arena.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Baker, H.W.G., Liu, D.Y., Bourne, H. and Lopata, A. 1993. Diagnosis of sperm defects in selecting patients for assisted fertilization. Hum. Reprod. 8: 1779–1780.
Sherins, R.J., Thorsell, L.P., Dorfmann, A., Dennison-Lagos, L., Calvo, L.P., Krysa, L., Coulam, C.B. and Schulman, J.D. Intracytoplasmic sperm injection facilitates fertilization even in the most severe forms of male infertility: pregnancy outcome correlates with maternal age and number of eggs available. Fertil. Steril. In press.
Overstreet, J.W. 1994. Clinical approach to male reproductive problems. Occup. Med. 9: 387–404.
Cross, N.L. and Meizel, S. 1989. Methods for evaluating the acrosomal status of mammalian sperm. Biol. Reprod. 41: 635–641.
Morales, P. and Cross, N.L. 1989. A new procedure for determining acrosomal status of very small numbers of human sperm. J. Histochem. Cytochem. 37: 1291–1292.
Mandelbaum, J., Junca, A.M., Plachot, M., Cayol, A., Cohen, J. and Salat-Baroux, J. 1993. Fertility tests (hamster, electronic microscopy): are they useful? Contracept. Fertil Sex. 21: 587–590.
Liu, D.Y. and Baker, H.W. 1992. Tests of human sperm function and fertilization in vitro [see comments]. Fertil. Steril. 58: 465–483.
Chang, Y.S., Lee, J.Y., Moon, S.Y., Kim, J.G., Pang, M.G. and Shin, C.J. 1990. Factors affecting penetration of zona-free hamster ova. Arch. Androl. 25: 213–224.
Ikawa, M., Ying, X., Tanaka, K., Ohashi, K., Saji, F. and Okabe, M. 1995. Improvement of fusing ability of human sperm to zona-free hamster eggs by conditioned media. Biol. Pharm. Bull. 18: 5–8.
Windsor, D.P., Evans, G. and White, I.G. 1993. Sex predetermination by separation of X and Y chromosome-bearing sperm: a review. Reprod. Fertil. Dev. 5: 155–171.
Foreman, R., Cohen, J.C.B., Fishel, S.B. and Edwards, R.G. 1984. The application of the zona-free hamster egg test for the prognosis of human in vitro fertilization. J. In Vitro Fert. Embryo Transfer 1: 166–171.
Zaneveld, L.J.D., De Jonge, C.J., Anderson, R.A. and Mack, S.R. 1991. Human sperm capacitation and the acrosome reaction. Hum. Reprod. 6: 1265–1274.
Kuzan, F.B., Muller, C.H., Zarutskie, P.W., Dixpn, L.L. and Soules, M.R. 1987. Human sperm penetration assay as an indicator of sperm function in human in vitro fertilization. Fertil. Steril. 48: 282–286.
Ausmanas, M., Tureck, R.W., Blasco, L., Kopf, G.S., Ribas, J. and Mastroianni Jr., L. 1995. The zona-free hamster egg penetration assay as a prognostic indicator in a human in vitro fertilization program. Fertil. Steril. 43: 433–437.
Palermo, G., Joris, H., Devroey, P. and Van Steirteghem, A.C. 1992. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet 340: 17–18.
Van Steirteghem, A., Nagy, Z., Liu, J., Joris, H., Verheyen, G., Smitz, J., Tournaye, H., Liebaers, I. and Devroey, P. 1994. Intracytoplasmic sperm injection. Baillieres. Clin. Obstet. Gynaecol. 8: 85–93.
Van Steirteghem, A.C., Nagy, Z., Joris, H., Liu, J., Staessen, C., Smitz, J., Wisanto, A. and Devroey, P. 1993. High fertilization and implantation rates after intracytoplasmic sperm injection. Hum. Reprod. 8: 1061–1066.
Van Steirteghem, A.C., Liu, J., Joris, H., Nagy, Z., Janssenswillen, C., Tournaye, H., Derde, M.P., Van Assche, E. and Devroey, P. 1993. Higher success rate by intracytoplasmic sperm injection than by subzonal insemination. Report of a second series of 300 consecutive treatment cycles. Hum. Reprod. 8: 1055–1060.
Stranc, L.C., Evans, J.A. and Hamerton, J.L. 1994. Prenatal diagnosis in Canada—1990: a review. Prenat. Diag. 14: 1253–1265.
Sutherland, G.R., Mulley, J.C. and Richards, R.I. 1993. Fragile X syndrome: the most common cause of familial intellectual handicap. Med. J. Aust. 158: 482–485.
Kremer, E.J., Pritchard, M., Lynch, M., Yu, S., Holman, K., Baker, E., Warren, S.T., Schlessinger, D., Sutherland, G.R. and Richards, R.I. 1991. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252: 1711–1714.
Oberlé, I., Rousseau, F., Heitz, D. et al. 1991. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252: 1097–1102.
Verkerk, A.J., Pieretti, M., Sutcliffe, J.S., Fu, Y.H., Kuhl, D.P., Pizzuti, A., Reiner, O., Richards, S., Victoria, M.F. and Zhang, F.P. 1991. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65: 905–914.
Rousseau, F., Rehel, R., Rouillard, P., DeGrandpre, P., Morgan, K. and Khandjian, E.W. 1993. Mutational prevalence of fragile X premutations in 10,624 females from the general population by Southern blotting. Am. J. Hum. Genet. 53: abstract 3.
Heitz, D., Devys, D., Imbert, G., Kretz, C. and Mandel, J.L. 1992. Inheritance of the fragile X syndrome: size of the fragile X premutation is a major determinant of the transition to full mutation. J. Med. Genet. 29: 794–801.
Turner, A.M., Robinson, H., Wake, S., Laing, S.J., Leigh, D. and Turner, G. 1994. Counselling risk figures for fragile X carrier females of varying band sizes for use in predicting the likelihood of retardation in their offspring. Am. J. Med. Genet. 51: 458–462.
Levinson, G., Maddalena, A., Palmer, F.T., Harton, G.L., Bick, D.P., Howard-Peebles, P.N., Black, S.H. and Schulman, J.D. 1994. Improved sizing of fragile X CCG repeats by nested polymerase chain reaction. Am. J. Med. Genet. 51: 527–534.
Blitzer, M.G. and McDowell, G.A. 1992. Tay-Sachs disease as a model for screening inborn errors. Clin. Lab. Med. 12: 463–480.
Horowitz, M., Tzuri, G., Eyal, N., Berebi, A., Kolodny, E.H., By Barton, N.W., Abrahamov, A. and Zimran, A. 1993. Prevalence of nine mutations among Jewish and non-Jewish Gaucher disease patients. Am. J. Hum. Genet. 53: 921–930.
Grabowski, G.A. 1993. Gaucher disease. Enzymology, genetics, and treatment. Adv. Hum. Genet. 21: 377–441.
Beutler, E. 1992. Gaucher disease: new molecular approaches to diagnosis and treatment. Science 256: 794–799.
Beutler, E. 1993. Modern diagnosis and treatment of Gaucher's disease. Am. J. Dis. Child 147: 1175–1183.
Sidransky, E., Tsuji, S., Martin, B.M., Stubblefleld, B. and Girms, E.I. 1992. DNA mutation analysis of Gaucher patients [see comments]. Am. J. Med. Genet. 42: 331–336.
Zimran, A., Gelbart, T., Westwood, B., Grabowski, G.A. and Beutler, E. 1991. High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews. Am. J. Hum. Genet. 49: 855–859.
Beutler, E., Nguyen, N.J., Henneberger, M., Henneberger, M.W., Smolec, J.M., McPherson, R. A., West, C. and Gelbart, T. 1993. Gaucher disease: gene frequencies in the Ashkenazi Jewish population. Am. J. Hum. Genet. 52: 85–88.
Mistry, P.K., Smith, S.J., Ali, M., Hatton, C.S., McIntyre, N. and Cox, T.M. 1992. Genetic diagnosis of Gaucher's disease. Lancet 339: 889–892.
Shoshani, T., Augarten, A., Gazit, E., Bashan, N., Yahav, Y., Rivlin, Y., Tal, A., Seret, H., Yaar, L. and Kerem, E. 1992. Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease. Am. J. Hum. Genet. 50: 222–228.
Kalman, Y.M., Kerem, E., Darvasi, A., DeMarchi, J. and Kerem, B. 1994. Difference in frequencies of the cystic fibrosis alleles, delta F508 and W1282X, between carriers and patients. Eur. J. Hum. Genet 2: 77–82.
Kaul, R., Gao, G.P., Balamurugan, K. and Matalon, R. 1994. Canavan disease: molecular basis of aspartoacylase deficiency. J. Inherit. Metab. Dis. 17: 295–297.
Matalon, R., Kaul, R. and Michals, K. 1994. Carrier rate of Canavan disease among Ashkenazi Jewish individuals. Am. J. Hum. Genet. 55 (suppl): A157
Kaul, R., Gao, G.P., Aloya, M., Balamurugan, K., Petrosky, A., Michals, K. and Matalon, R. 1994. Canavan disease: mutations among Jewish and non-jewish patients. Am. J. Horn. Genet. 55: 34–41.
Traeger-Synodinos, J., Kanavakis, E., Tzetis, M., Katlarajs, A. and Kattamis, C. 1993. Characterization of nondeletion alpha-thalassemia mutations in the Greek population. Am. J. Hematol. 44: 162–167.
Viniou, N., Georgiou, J., Loutradi, A., Rombos, J., Fessas, P. and Loukopoulos, D. 1994. Molecular basis and haplotype analysis of delta, beta-thalassemic chromosomes in Greece. Acta Haematol. 92: 83–87.
Howard-Peebles, P.N., Maddalena, A., Spence, W.C., Levinson, G., Fallon, L., Bick, D.P., Black, S.H. and Schulman, J.D. 1994. Fragile X screening: what is the real issue?[letter]. Am. J. Med. Genet. 53: 382.
MacDonald, M.E. et al. (Hunrington's Disease Collaborative Research Group). 1993. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72: 971–983.
Handyside, A.H., Pattinson, J.K., Penkem, R.J., Delhanty, J.D., Winston, R.M. and Tuddenham, E.G. 1989. Biopsy of human preimplantation embryos and sexing by DNA amplification. Lancet 1: 347–349.
Handyside, A.H., Kontogianni, E.H., Hardy, K. and Winston, R.M. 1990. Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature 344: 768–770.
Verlinsky, Y., Handyside, A., Grifo, J. et al. 1994. Preimplantation diagnosis of genetic and chromosomal disorders. J. Asst. Reprod. Genet. 11: 236–243
Verlinsky, Y., Handyside, A., Simpson, J.L. et al. 1993. Current progress in preimplantation genetic diagnosis. J. Asst. Reprod. Genet. 10: 353–360.
Black, S.H. 1994. Preimplantation genetic diagnosis. Curr. Opinion Peds 6: 712–716.
Delhanty, J.D.A. 1994. Preimplantation diagnosis. Prenat. Diagn. 14: 1217–1227.
Mullis, K., Faloona, F., Scharf, S., Saiki, R., Horn, G. and Erlich, H. 1986. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb. Symp. Quant. Biol. 51 Pt 1: 263–273.
Saiki, R.K., Gelfand, D.H., Stoffel, S., Scharf, S.J., Higuchi, R., Horn, G.T., Mullis, K.B. and Erlich, H.A. 1988. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487–491.
Arnheim, N. and Erlich, H. 1992. Polymerase chain reaction strategy. Annu. Rev. Biochem. 61: 131–156.
Erlich, H.A. and Amheim, N. 1992. Genetic analysis using the polymerase chain reaction. Annu. Rev. Genet. 26: 479–506.
Zhang, L., Cui, X., Schmitt, K., Hubert, R., Navidi, W. and Amheim, N. 1992. Whole genome amplification from a single cell: implications for genetic analysis. Proc. Nad. Acad. Sci. USA 89: 5847–5851.
Levinson, G., Fields, R.A., Harton, G.L., Palmer, F.T., Maddalena, A., Fugger, E.F. and Schulman, J.D. 1992. Reliable gender screening for human preimplantation embryos, using multiple DNA target-sequences. Hum. Reprod. 7: 1304–1313.
Navidi, W., Arnheim, N. and Waterman, M.S. 1992. A multiple-tubes approach for accurate genotyping of very small DNA samples by using PCR: statistical considerations. Am. J. Hum. Genet. 50: 347–359.
Levinson, G., Maddalena, A., Palmer, F.T., Harton, G.L., Bick, D.P., Howard-Peebles, P.N., Black, S.H. and Schulman, J.D. 1992. Improved sizing of fragile X CCG repeats by nested polymerase chain reaction. Am. J. Med. Genet. 51: 527–534.
Levinson, G., Maddalena, A., Howard-Peebles, P.N., Black, S.H., Fugger, E.F., Palmer, F.T., Harton, G.L., Fields, R., Neel, B.L., Clifford, N.D. and Schulman, J.D. 1992. Preimplantation genetic screening: an option for families at risk for transmission of the fragile X chromosome. International Fragile X Proceedings, Snowmass, CO, p. 383.
Levinson, G., Sisson, M.E., Harton, G.L., Palmer, F.T., Fields, R.A., Black, S.H., Fugger, E.F., Maddalena, A. and Schulman, J.D. 1994. Preimplantation genetic testing for X-linked disorders and cystic fibrosis. 7th Int. Conf. on Early Prenatal Diagnosis, Jerusalem.
Morrison, K.E., Daniels, R.J., Suthers, G.K. et al. 1992. High-resolution genetic map around the spinal muscular atrophy (SMA) locus on chromosome 5. Am. J. Hum. Genet. 50: 520–527.
Roy, N., Mahadevan, M.S., McLean, M. et al. 1995. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80: 167–178.
Lefebvre, S., Burglen, L., Reboullet, S. et al. 1995. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80: 155–165.
Munne, S., Tang, Y.X., Grifo, J., Rosenwaks, Z. and Cohen, J. 1994. Sex determination of human embryos using the polymerase chain reaction and confirmation by fluorescence in situ hybridization. Fertil. Steril. 61: 111–117.
Munne, S., Weier, H.U., Stein, J., Grifo, J. and Cohen, J. 1993. A fast and efficient method for simultaneous X and Y in situ hybridization of human blastomeres. J. Assist. Reprod. Genet. 10: 82–90.
Griffin, D.W., Wilton, L.J., Handyside, A.H., Atkinson, G.H.G., Winston, R.M.L. and Delhanty, J.H.A. 1993. Diagnosis of sex in preimplantation embryos by fluorescent in situ hybridization. B. M. J. 306: 1382.
Coonen, E., Harper, J.C., Ramaekers, F.C.S. et al. 1994. Presence of chromosomal mosaicism in abnormal preimplantation embryos detected by fluorescence in situ hybridisation. Hum. Genet. 94: 609–615.
Harper, J.C., Coonen, E., Handyside, A.H., Winston, R.M.L., Hopman, A.H.N. and Delhanty, J.D.A. 1995. Mosaicism of autosomes and sex chromosomes in morphologically normal, monospermic preimplantation human embryos. Prenat. Diagn. 15: 41–49.
Munne, S., Weier, H.U., Grifo, J. and Cohen, J. 1994. Chromosome mosaicism in human embryos. Biol. Reprod. 51: 373–379.
Munne, S., Grifo, J., Cohen, J., Weier, H.U. 1994. Chromosome abnormalities in human arrested preimplantation embryos: a multiple-probe FISH study. Am. J. Hum. Genet. 55: 150–159.
Munne, S., Lee, A., Rosenwaks, Z., Grifo, J. and Cohen, J. 1993. Diagnosis of major chromosome aneuploidies in human preimplantation embryos. Hum. Reprod. 8: 2185–2191.
Wolstenholme, J. 1995. An audit of trisomy 16 in man. Prenat. Diagn. 15: 109–121.
Johnson, L.A. and Pinkel, D. 1986. Modification of a laser-based flow cytometer for high-resolution DNA analysis of mammalian spermatozoa. Cytometry 7: 268–273.
Johnson, L.A., Flook, J.P. and Hawk, H.W. 1989. Sex preselection in rabbits: live births from X and Y sperm separated by DNA and cell sorting. Biol. Reprod. 41: 199–203.
Johnson, L.A., Welch, G.R., Keyvanfar, K., Dorfmann, A., Fugger, E.F. and Schulman, J.D. 1993. Gender preselection in humans? Flow cytometric separation of X and Y spermatozoa for the prevention of X-linked diseases. Hum. Reprod. 8: 1733–1739.
Edwards, R.G. and Beard, H.K. 1995. Sexing human spermatozoa to control sex ratios at birth now a reality. Mol. Hum. Reprod. 1: 977–978.
Cran, D.G., Johnson, L.A., Miller, N.G., Cochrane, D. and Polge, C. 1993. Production of bovine calves following separation of X- and Y-chromosome bearing sperm and in vitro fertilisation. Vet. Rec. 132: 40–41.
Johnson, L.A. and Schulman, J.D. 1994. The safety of sperm selection by flow cytometry. Hum. Reprod. 9: 758–759.
Johnson, L.A. and Clarke, R.N. 1988. Flow sorting of X andY chromosome-bearing mammalian sperm: activation and pronuclear development of sorted bull, boar, and ram sperm microinjected into hamster oocytes. Gamete Res. 21: 335–343.
Libbus, B.L., Perreault, S.D., Johnson, L.A. and Pinkel, D. 1987. Incidence of chromosome aberrations in mammalian sperm stained with Hoechst 33342 and UV-laser irradiated during flow sorting. Mutat. Res. 182: 265–274.
Johnson, L.A., Flook, J.P. and Look, M.V. 1987. Flow cytometry of X and Y chromosome-bearing sperm for DNA using an improved preparation method and staining with Hoechst 33342. Gamete Res. 17: 203–212.
Windsor, D.P., Evans, G., White, I.G. 1993. Sex predetermination by separation of X and Y chromosome-bearing sperm: a review. Reprod. Fertil. Dev. 5: 155–171.
Levinson, G., Keyvanfar, K., Wu, J.C. et al. 1995. DNA-based X-enriched sperm separation as an adjunct to preimplantation genetic testing for the prevention of X-linked disease. Molecular Human Reproduction 10: 979–982.
Stern, J.J. and Coulam, C.B. 1993. Current status of immunologic recurrent pregnancy loss. Curr. Opin. Obstet. Gynecol. 5: 252–259.
Shern, J.J., Dorfmann, A., Guierrez-Najar, A.J., Cerrillo, M. and Coulam, C.B. Frequency of abnormal karyotype among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil. Steril. In press.
Coulam, C.B. Immunotherapy for recurrent spontaneous abortion. Early pregnancy: Biol. Med. 1: 1–14.
Coulam, C.B., Goodman, C., Roussev, R.O., Thomason, E.J. and Beaman, K.D. 1995. Systemic CD56+ cells can predict pregnancy outcome. Am. J. Reorod. Immunol. 33: 40–46.
Coulam, C.B., Krysa, L.W. and Bustillo, M. 1994. Intravenous immuno-globulin for in-vitro fertilization failure. Hum. Reprod. 9: 2265–2269.
Mueller-Eckhardt, G. 1994. Immunotherapy with intravenous imtnunoglobu-lin for prevention of recurrent pregnancy loss: European experience. Am. J. Reprod. Immunol. 32: 281–285.
German RSA/IVIG Group. 1994. Intravenous immunoglobulin in the prevention of recurrent miscarriage. The German RSA/IVIG Group. Br. J. Obstet. Gynaecol. 101: 1072–1077.
Coulam, C.B. 1994. Immunotherapy with intravenous immunoglobulin for treatment of recurrent pregnancy loss: American experience. Am. J. Reprod. Immunol. 32: 286–289.
De Placido, G., Zullo, F., Mollo, A., Cappiello, F., Nazzaro, A., Colacurci, N. and Palumbo, G. 1994. Intravenous immunoglobulin (IVIG) in the prevention of implantation failures. Ann. N. Y. Acad. Sci. 734: 232–234.
Crandall, B.F. 1981. Alpha-fetoprotein: a review. Crit. Rev. Clin. Lab. Sci. 15: 127–185.
Shoenfeld DiMaio, M., Baumgarten, A., Greenstein, R.M., Saal, H.M. and Mahoney, M.J. 1987. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels. New Engl. J. Med. 317: 342–346.
Haddow, J.E., Palomaki, G.E., Knight, G.J. et al. 1992. Prenatal screening for Down's syndrome with use of maternal serum markers. New Engl. J. Med. 588–593?.
Brizot, M.L., Kuhn, P., Bersinger, N.A., Snijders, R.J. and Nicolaides, K.H. 1995. First trimester maternal serum alpha-fetoprotein in fetal trisomies. Br. J. Obstet. Gynaecol. 102: 31–34.
Hurley, P.A., Ward, R.H.T., Teisner, B., Iles, R. K., Lucas, M. and Grudzinskas, J. G. 1993. Serum PAPP-A measurements in first-trimester Down syndrome. Prenatal Diagnosis 13: 903–908.
Chueh, J. and Golbus, M.S. 1991. The search for fetal cells in the maternal circulation. J. Perinat. Med. 19: 411–420.
Lo, Y.D., Patel, P., Wainscoat, J.S., Sampietro, M., Gillmer, M.D.G. and Fleming, K.A. 1989. Prenatal sex determination by DNA amplification from maternal peripheral blood. Lancet ii: 1363–1365.
Simpson, J.L. and Elias, S. 1993. Isolating fetal cells from maternal blood. Advances in prenatal diagnosis through molecular technology [see comments]. JAMA 270: 2357–2361.
Bianchi, D.W., Zickwolf, G.K., Yih, M.C., Flint, A.F., Geifman, O.H., Erikson, M.S. and Williams, J.M. 1993. Erythroid-specific antibodies enhance detection of fetal nucleated erythrocytes in maternal blood. Prenat. Diagn. 13: 293–300.
Hamada, H., Arinami, T., Kubo, T., Hamaguchi, H. and Iwasaki, H. 1993. Fetal nucleated cells in maternal peripheral blood: frequency and relationship to gestational age. Hum. Genet. 91: 427–432.
Zheng, Y.L., Carter, N.P., Price, C.M., Colman, S.M., Milton, P.J., Hackett, G.A., Greaves, M.F. and Ferguson-Smith, M.A. 1993. Prenatal diagnosis from maternal blood: simultaneous immunophenotyping and FISH of fetal nucleated erythrocytes isolated by negative magnetic cell sorting. J. Med. Genet. 30: 1051–1056.
Lo, Y.-M.D., Patel, P., Baigent, C.N. et al. 1993. Prenatal sex determination from maternal peripheral blood using the polymerase chain reaction. Hum. Genet. 90: 483–488.
Ganshirt-Ahlert, D., Borjesson-Stoll, R., Burschyk, M. et al. 1993. Detection of fetal trisomies 21 and 18 from maternal blood using triple gradient and magnetic cell sorting. Am. J. Repro. Immunol. 30: 194–201.
Busch, J., Huber, P., Holtz, J., Pfluger, E. and Radbruch, A. 1994. Simple and fast double-MACS sorting of fetal erythroblasts from maternal blood for PCR-based paternity analysis. Ann. N. Y. Acad. Sci. 731: 144–146.
Bianchi, D.W., Flint, A.F., Pizzimenti, M.F., Knoll, J.H.M. and Latt, S.A. 1990. Isolation of fetal DNA from nucleated erythrocytes in maternal blood. Proc. Natl. Acad. Sci. USA 87: 3279–3283.
Reading, J.P., Huffman, J.L., Wu, J.C., Palmer, F.T., Harton, G.L., Sisson, M.E., Keyvanfar, K., Gresinger, T.H., Cochrane, W.J., Fallen, L.A., Menapace-Drew, G.F., Cummings, E.A., Jones, S.L., Black, S.H., Schulman, J.D. and Levinson, G. Nucleated erythrocytes in maternal blood: quantity and quality of fetal cells in enriched populations. Mol Hum Reprod. In press.
Levinson, G., Reading, J.P., Huffman, J.L., Wu, J.C., Sisson, M.E., Palmer, F.T., Harton, G.L., Keyvanfar, K., Black, S.H. and Schulman, J.D. 1994. Erythroid progenitors in maternal blood and analysis of fetal origins. 7th international conference on early prenatal diagnosis. From fertilization to fetus: detection of geno-phenotype diversities, pp. 27–33.
Silverman, E.K., Miletich, J.P., Pierce, J.A. et al. 1989. Alpha-1-antitrypsin deficiency: high prevalence in the St. Louis area determined by direct population screening. Am. Rev. Respir. Dis. 140: 961–966.
Tazelaar, J.P., Friedman, K.J., Kline, R.S., Guthrie, M.L., Farber, R.A. 1992. Detection of alpha-1-antitrypsin Z and S mutations by polymerase chain reaction-mediated site-directed mutagenesis. Clin. Chem. 38: 1486–1488.
Beaudet, A.L. 1992. Genetic testing for cystic fibrosis. Pediatr. Clin. North Am. 39: 213–228.
Tsui, L.C. 1992. The spectrum of cystic fibrosis mutations. Trends. Genet. 8: 392–398.
Beggs, A.H. and Kunkel, L.M. 1990. Improved diagnosis of Duchenne/Becker muscular dystrophy. J. Clin. Invest. 85: 613–619.
Warren, S.T. and Nelson, D.L. 1994. Advances in molecular analysis of fragile X syndrome [see comments]. JAMA 271: 536–542.
Lakich, D., Kazazian, H.H., Jr Antonarakis, S.E. and Gitschier, J. 1993. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat. Genet. 5: 236–241.
Zuhlke, C., Riess, O., Bockel, B., Lange, H. and Thies, U. 1993. Mitotic stability and meiotic variability of the (CAG)n repeat in the Huntington disease gene. Hum. Mol. Genet. 2: 2063–2067.
Shelboume, P., Davies, J., Buxton, J., Anvret, M., Blennow, E., Bonduelle, M., Schmedding, E., Glass, I., Lindenbaum, R. and Lane, R. 1993. Direct diagnosis of myotonic dystrophy with a disease-specific DNA marker. N. Engl. J. Med. 328: 471–475.
Thompson, M.W., McInnes, R.R. and Willard, H.F. 1995. Genetics in medicine. 5th ed. W. B. Saunders, Philadelphia, p. 62.
Schechter, A.N., Noguchi, C.T., Rodgers, G.P., 1987. In: Basis of Blood Diseases, p. 179–218. Stamatoyannopoulos, G., Nienhuis, A. W., Leder, P. and Majerus, P. W. (Eds.). W. B., Saunders, Philadelphia.
Strasberg, P.M. and Clarke, J.T. 1992. Rapid nonradioactive tracer method for detecting carriers of the major Ashkenazi Jewish Tay-Sachs disease mutations [published erratum appears in Clin Chem 1993 Feb;39(2):371]. Clin. Chem. 38: 2249–2255.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Levinson, G., Coulam, C., Spence, W. et al. Recent Advances in Reproductive Genetic Technologies. Nat Biotechnol 13, 968–973 (1995). https://doi.org/10.1038/nbt0995-968
Issue date:
DOI: https://doi.org/10.1038/nbt0995-968